A Simple In Vitro Test to Select Stools for Fecal Microbiota Transplantation to Limit Intestinal Carriage of Extensively Drug-Resistant Bacteria

Archive ouverte

Salandre, Angélique | Delannoy, Johanne | Goudiaby, Marie, Thérèse Barba | Thomas, Muriel | Barbut, Frédéric | Waligora-Dupriet, Anne-Judith | Kapel, Nathalie

Edité par CCSD ; MDPI -

International audience. Treatment options for multidrug-resistant bacterial infections are limited and often ineffective. Fecal microbiota transplantation (FMT) has emerged as a promising therapy for intestinal multidrug-resistant bacterial decolonization. However, clinical results are discrepant. The aim of our pilot study was to evaluate the screening performance of a simple diagnostic tool to select fecal samples that will be effective in decolonizing the intestine. Fecal samples from 10 healthy subjects were selected. We developed an agar spot test to evaluate their antagonistic activity toward the growth of VanA Enterococcus faecium and OXA-48-producing Klebsiella pneumoniae, two of the most serious and urgent threats of antibiotic resistance. Most fecal samples were able to limit the growth of both bacteria in vitro but with large inter-individual variation. The samples with the highest and lowest antagonistic activity were used for FMT in a mouse model of intestinal colonization. FMT was not successful in reducing intestinal colonization with VanA Enterococcus faecium, whereas FMT performed with the fecal sample showing the highest activity on the agar spot test was able to significantly reduce the intestinal colonization of mice with Klebsiella pneumoniae OXA-48. The agar spot test could thus serve as a reliable screening tool to select stool samples with the best potential to eradicate/reduce multidrug-resistant bacteria carriage after FMT.

Suggestions

Du même auteur

Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine models

Archive ouverte | Reygner, Julie | CCSD

International audience. Growing evidence demonstrates the key role of the gut microbiota in human health and disease. The recent success of microbiotherapy products to treat recurrent Clostridioides difficile infect...

lyophilized composition for preserving microbiota in its ecosystem. COMPOSITION LYOPHILISEE POUR LA CONSERVATION DE MICROBIOTE DANS SON ECOSYSTEME

Archive ouverte | Thomas, Muriel | CCSD

Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model ofClostridioides difficileinfection

Archive ouverte | Reygner, Julie | CCSD

International audience. Fecal microbiota transplantation is now recommended for treating recurrent forms ofClostridioides difficileinfection. Recent studies have reported protocols using capsules of either frozen or...

Chargement des enrichissements...